Amexdrug Corp. Stock Analysis AXRX
Amexdrug Corp. engages in the pharmaceutical, medical, and cosmeceutical industries. The company is headquartered in Beverly Hills, California and currently employs 9 full-time employees. The firm has eight business units, including Dermagen Inc., BioRx Pharma, BioRx Laboratories, Sponix Products, Royal Health Care, Amexhealth Plan and BioRx Labels. Dermagen Inc. manufactures pharmaceutical and skincare products, contract packaging and private labeling. BioRx Pharma unit is a manufacturer and distributor of pharmacy supplies, packaging and other health-care related products for pharmacy operations. BioRx Laboratories unit is a manufacturer and distributor of lab supplies and other related products for lab operations. BioRx Labels unit is a service provider of pharmacy labels. Sponix Products unit is health and wellness products for total health care. Royal Health Care develops and distributes nutraceuticals, nutritional supplements, vitamins and all-natural skincare products.
Read More Amexdrug Corp (AXRX) Chart
Key Statistics of Amexdrug Corp (AXRX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
4000.00P/E Ratio (TTM)
0.4152 Week Range
Market Cap
33.88KAvg. Volume
2160.00Dividend Yield
-Financial Metrics & Statements of Amexdrug Corp (AXRX)
FAQ's for Amexdrug Corp (AXRX)
- According to Musaffa’s Shariah screening methodology, Amexdrug Corp (AXRX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.